Iris Walraven

1.5k citations

67 papers · 939 · h-index 18

Impact in

Radiation top 5%
- Advanced Radiotherapy Techniques
Otorhinolaryngology top 5%

Papers in

Pulmonary and Respiratory Medicine 38
- Lung Cancer Diagnosis and Treatment 16
- Lung Cancer Treatments and Mutations 12
- Prostate Cancer Diagnosis and Treatment 6
Oncology 22
- Cancer survivorship and care 9
- Lung Cancer Research Studies 8

Co-authors: J. Belderbos (16 shared papers)Floris J. Pos (8 shared papers)Uulke A. van der Heide (8 shared papers)Joost Dekker (9 shared papers)Giel Nijpels (9 shared papers)Marcel Verheij (9 shared papers)Petra J. M. Elders (7 shared papers)Berlinda J. de Wit–van der Veen (4 shared papers)
Journals: Radiotherapy and Oncology (8 papers)Cancers (4 papers)Cancer (3 papers)Annals of Oncology (3 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)
Partner nations: Netherlands United States Germany

In The Last Decade

Iris Walraven

61 papers receiving 930 citations

Peers

Countries citing papers authored by Iris Walraven

Since Specialization

Citations

This map shows the geographic impact of Iris Walraven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Walraven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Walraven more than expected).

Fields of papers citing papers by Iris Walraven

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris Walraven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Walraven. The network helps show where Iris Walraven may publish in the future.

Co-authors

The 25 scholars most cited alongside Iris Walraven, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Iris Walraven Line = papers co-authored together Iris Walraven links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Standard whole prostate gland radiotherapy with and without lesion boost in prostate cancer: Toxicity in the FLAME randomized controlled trial Radiotherapy and Oncology ·Evelyn M. Monninkhof, Juliette W. L. van Loon, Marco van Vulpen, Linda G.W. Kerkmeijer, Floris J. Pos, Karin Haustermans, Laura Van den Bergh, Sofie Isebaert, G. McColl, Robert Jan Smeenk, Juus L Noteboom, Iris Walraven, Petra H.M. Peeters, Uulke A. van der Heide	2018	96
2	Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab Radiotherapy and Oncology ·Iris Walraven, Michel M. van den Heuvel, Judi van Diessen, Eva Schaake, Wilma Uyterlinde, Joachim G.J.V. Aerts, Frederieke Koppe, Henk Codrington, Peter W.A. Kunst, Edith Dieleman, Paul van de Vaart, Marcel Verheij, J. Belderbos	2016	54
3	Distinct HbA1c trajectories in a type 2 diabetes cohort Acta Diabetologica ·Iris Walraven, Mareike Mast, Trynke Hoekstra, A. P. D. Jansen, Amber A. van der Heijden, Simone P. Rauh, Femke Rutters, Esther van ‘t Riet, Petra J. M. Elders, Annette C. Moll, B.C.P. Polak, Joost Dekker, Giel Nijpels	2014	48
4	Early response assessment and prediction of overall survival after peptide receptor radionuclide therapy Cancer Imaging ·Daphne M. V. de Vries–Huizing, Else A. Aalbersberg, Michelle W. J. Versleijen, Margot Tesselaar, Iris Walraven, Max J. Lahaye, Berlinda J. de Wit–van der Veen, Marcel P. M. Stokkel	2020	41
5	Adjuvant chemotherapy is superior to chemoradiation after D2 surgery for gastric cancer in the per-protocol analysis of the randomized CRITICS trial Annals of Oncology ·Wobbe O. de Steur, Romy M. van Amelsfoort, H.H. Hartgrink, Hein Putter, Elma Meershoek‐Klein Kranenbarg, Nicole C.T. van Grieken, J.W. van Sandick, Y.H.M. Claassen, Jeffrey P. B. M. Braak, Edwin P. M. Jansen, Karolina Sikorska, Harm van Tinteren, Iris Walraven, P Lind, Marianne Nordsmark, Mark I. van Berge Henegouwen, Hanneke W.M. van Laarhoven, Annemieke Cats, Marcel Verheij, Cornelis J.�H. van de Velde	2020	40
6	Extrameningeal solitary fibrous tumors—surgery alone or surgery plus perioperative radiotherapy: A retrospective study from the global solitary fibrous tumor initiative in collaboration with the Sarcoma Patients EuroNet Cancer ·Rick L. Haas, Iris Walraven, Estelle Lecointe‐Artzner, Winan J. van Houdt, D. Strauß, Yvonne Schrage, Andrew Hayes, Chandrajit P. Raut, Mark Fairweather, Elizabeth H. Baldini, Alessandro Gronchi, Laura De Rosa, Anthony M. Griffin, Peter C. Ferguson, Jay S. Wunder, Michiel A. J. van de Sande, Augustinus D. G. Krol, J. Skoczylas, Claudia Sangalli, Silvia Stacchiotti	2020	39
7	Radiation Therapy as Sole Management for Solitary Fibrous Tumors (SFT): A Retrospective Study From the Global SFT Initiative in Collaboration With the Sarcoma Patients EuroNet International Journal of Radiation OncologyBiologyPhysics ·Rick L. Haas, Iris Walraven, Estelle Lecointe‐Artzner, Astrid N. Scholten, Winan J. van Houdt, Anthony M. Griffin, Peter C. Ferguson, Aisha Miah, Shaine Zaidi, Thomas F. DeLaney, Yen‐Lin Chen, Mateusz Spałek, Augustinus D. G. Krol, Rieneke G. Moeri-Schimmel, Michiel A. J. van de Sande, Claudia Sangalli, Silvia Stacchiotti	2018	38
8	SPECT/CT-guided elective nodal irradiation for head and neck cancer is oncologically safe and less toxic: A potentially practice-changing approach Radiotherapy and Oncology ·Pieter D. de Veij Mestdagh, Iris Walraven, Wouter V. Vogel, Willem H. Schreuder, Erik van Werkhoven, C. Carbaat, Maarten L. Donswijk, Michiel W. M. van den Brekel, Abrahim Al‐Mamgani	2020	36
9	Parameters to Predict Progression-Free and Overall Survival After Peptide Receptor Radionuclide Therapy: A Multivariate Analysis in 782 Patients Journal of Nuclear Medicine ·Else A. Aalbersberg, Daphne M. V. de Vries–Huizing, Iris Walraven, Berlinda J. de Wit–van der Veen, Harshad Kulkarni, Aviral Singh, Marcel P. M. Stokkel, Richard P. Baum	2019	32
10	Biochemical recurrence prediction after radiotherapy for prostate cancer with T2w magnetic resonance imaging radiomic features Physics and Imaging in Radiation Oncology ·Catarina Dinis Fernandes, Cuong V. Dinh, Iris Walraven, Stijn Heijmink, Milena Smolic, Joost J. M. van Griethuysen, Rita Simões, Are Losnegård, Henk G. van der Poel, Floris J. Pos, Uulke A. van der Heide	2018	32
11	Validation of a model to estimate personalised screening frequency to monitor diabetic retinopathy Diabetologia ·Amber A. van der Heijden, Iris Walraven, Esther van ‘t Riet, Thor Aspelund, Sigrún H. Lund, Petra J. M. Elders, B.C.P. Polak, Annette C. Moll, Jan E.E. Keunen, Joost Dekker, Giel Nijpels	2014	32
12	Outcome of radical local treatment of non-small cell lung cancer patients with synchronous oligometastases Lung Cancer ·Margriet Kwint, Iris Walraven, Sjaak Burgers, Koen J. Hartemink, Houke M. Klomp, J. Knegjens, Marcel Verheij, J. Belderbos	2017	30
13	Treatment Variation of Sequential versus Concurrent Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer Patients in the Netherlands and Belgium Clinical Oncology ·Iris Walraven, Ronald Damhuis, Martijn Geert ten Berge, Michael Rosskamp, Liesbet Van Eycken, Dirk De Ruysscher, J. Belderbos	2017	29
14	A Narrative Review on the Collection and Use of Electronic Patient-Reported Outcomes in Cancer Survivorship Care with Emphasis on Symptom Monitoring Current Oncology ·Corina van den Hurk, Floortje Mols, Manuela Eicher, Raymond J. Chan, Annemarie Becker‐Commissaris, Gijs Geleijnse, Iris Walraven, Annemarie Coolbrandt, Maryam B. Lustberg, Galina Velikova, Andreas Charalambous, Bogda Koczwara, Doris Howell, Ethan Basch, Lonneke V. van de Poll‐Franse	2022	26
15	Visualization formats of patient-reported outcome measures in clinical practice: a systematic review about preferences and interpretation accuracy Journal of Patient-Reported Outcomes ·E A C Albers, Itske Fraterman, Iris Walraven, Erica A. Wilthagen, Sanne B. Schagen, Iris M. C. van der Ploeg, Michel W.J.M. Wouters, Lonneke V. van de Poll‐Franse, Kelly M. de Ligt	2022	23
16	Quantitative 3T multiparametric MRI of benign and malignant prostatic tissue in patients with and without local recurrent prostate cancer after external‐beam radiation therapy Journal of Magnetic Resonance Imaging ·Catarina Dinis Fernandes, Petra J. van Houdt, Stijn W. T. P. J. Heijmink, Iris Walraven, Rick Keesman, Milena Smolic, Ghazaleh Ghobadi, Henk G. van der Poel, Ivo G. Schoots, Floris J. Pos, Uulke A. van der Heide	2018	20
17	Quantitative MRI Changes During Weekly Ultra-Hypofractionated Prostate Cancer Radiotherapy With Integrated Boost Frontiers in Oncology ·Marcel A. van Schie, Petra J. van Houdt, Ghazaleh Ghobadi, Floris J. Pos, Iris Walraven, Hans C.J. de Boer, Cornelis A. T. van den Berg, Robert Jan Smeenk, Linda G.W. Kerkmeijer, Uulke A. van der Heide	2019	18
18	Time to insulin initiation and long-term effects of initiating insulin in people with type 2 diabetes mellitus: the Hoorn Diabetes Care System Cohort Study European Journal of Endocrinology ·Ruth Mast, A. P. D. Jansen, Iris Walraven, Simone P. Rauh, Amber A. van der Heijden, Robert J. Heine, Petra J. M. Elders, Joost Dekker, Giel Nijpels, Jacqueline G. Hugtenburg	2016	18
19	Organ-preservation (chemo)radiotherapy for T4 laryngeal and hypopharyngeal cancer: is the effort worth? European Archives of Oto-Rhino-Laryngology ·Abrahim Al‐Mamgani, Arash Navran, Iris Walraven, Willen Hans Schreuder, Margot Tesselaar, W. Martin C. Klop	2018	17
20	Knowledge-Based Assessment of Focal Dose Escalation Treatment Plans in Prostate Cancer International Journal of Radiation OncologyBiologyPhysics ·Marcel A. van Schie, Tomas Janssen, D. Eekhout, Iris Walraven, Floris J. Pos, Peter de Ruiter, A.N.T.J. Kotte, Evelyn M. Monninkhof, Linda G.W. Kerkmeijer, Cédric Draulans, Robin De Roover, Karin Haustermans, Martina Kunze-Busch, Robert Jan Smeenk, Uulke A. van der Heide	2020	16

About Iris Walraven

Iris Walraven is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Public Health, Environmental and Occupational Health and Radiation, having authored 67 papers that have together received 939 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (16 papers), Lung Cancer Treatments and Mutations (12 papers), Advanced Radiotherapy Techniques (9 papers), Cancer survivorship and care (9 papers), Lung Cancer Research Studies (8 papers), Prostate Cancer Diagnosis and Treatment (6 papers), Head and Neck Cancer Studies (6 papers) and Childhood Cancer Survivors' Quality of Life (6 papers). The work is most often cited by research in Radiation (143 citations), Otorhinolaryngology (71 citations), Pulmonary and Respiratory Medicine (479 citations), Oncology (251 citations) and Radiology, Nuclear Medicine and Imaging (203 citations). Iris Walraven has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include J. Belderbos, Floris J. Pos, Uulke A. van der Heide, Joost Dekker, Giel Nijpels, Marcel Verheij, Petra J. M. Elders, Berlinda J. de Wit–van der Veen, Else A. Aalbersberg and Amber A. van der Heijden. Their work appears in journals such as Radiotherapy and Oncology, Cancers, Cancer, Annals of Oncology and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Iris Walraven

Impact in

Papers in i

In The Last Decade

Iris Walraven

Peers

Countries citing papers authored by Iris Walraven

Fields of papers citing papers by Iris Walraven

All Works

About Iris Walraven

Explore authors with similar magnitude of impact

Papers in